dabigatran 150 mg

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Atrial FibrillationHeart CatheterizationHemorrhage

Phase 2

Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention

CompletedNCT00818753

Boehringer IngelheimHeart Catheterization

Start: 2009-01-31Updated: 2014-06-09

Unknown Phase

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

CompletedNCT02149303

Boehringer IngelheimAtrial Fibrillation, Hemorrhage

Start: 2014-06-30End: 2015-03-31Updated: 2016-04-04